Covaxin human trials start at SRM medical college

Minister Vijayabaskar requested Covid19 patients to donate Plasma in Tamil Nadu

Minister Vijayabaskar requested Covid19 patients to donate Plasma in Tamil Nadu

Two persons given the Covaxin COVID 19 vaccine today, July 23 in SRM Medical, are stable, confirm doctors. After observing their health for the next six hours, they will be sent home to come back after 14 days for another shot of the indigenous COVID 19 vaccine.

And it will continue for 194 days by adding up to 50 more such volunteers for the first phase of human clinical trials. Dr. Satyajit Mohapatra will be the principal investigator for this trial reporting to the ICMR periodically. Minister Udayakumar today confirms of soon opening plasma bank in Madurai after opening its opening in Chennai yesterday.

Rupees 2 lakh fine for COVID 19 rule violations

Deaths fast reaching 30,000 in India, and infections now at 12,38,635 cases including yesterday’s highest infections of 45,720 cases. The central cabinet of the minister approves Rs. 2 lakh fine for those violating COVID 19 rules for which the details are awaited. Irrespective of the lockdown and relaxations the infections and deaths are skyrocketing for the past five months.

Hence the only option for the people to live and have a livelihood is on the Covaxin vaccine results currently under testing in 5 out of the 12 centers for its first phase human clinical t trials. But, as per WHO and even the doctors of the concerned hospitals confirm of the use of such successful vaccines only next year 2021.

SRM Medical college Kattangulathur near Chennai

SRM Medical college in Kattangulathur in Chennai is one of the 12 hospitals selected by ICMR for the first phase of the Covaxin vaccine for COVID 19 prevention developed within India. It is a project approved by the DGCI and now under process by combining Bharat Biotech of Hyderabad, ICMR, and the National Institute of Virology, Pune.

In the first week of July, there was a letter from the ICMR to all these 12 hospitals to quickly track the process to bring out the vaccine’s usage by August 15. After concerns raised by the scientific community on the safety of the volunteers and the efficacy of the vaccine within a short period, ICMR clarified it only against administrative blocks in testing the vaccine.

Dr. Sangeetha of SRM College says the first injected person is safe and stable

Dr. Sangeetha is the professor of the SRM College spoke to the media about the first person who was injected with the indigenous vaccine. She confirmed that the person is stable and will be observed for the next six hours. After that, the person will be sent home and get one more shot of the vaccine after 14 days.

It will continue for 194 days for checking the increase of the antibodies until knowing full details of it. She also requested people to participate in the testing as it is safe voluntarily.

Covaxin is one of the more than 100 vaccines in the first phase of the human clinical trials. Only five are in the second phase, and the most promising one is the vaccine developed by Oxford University. It has proved in the first human clinical trial of producing enough antibodies to fight the coronavirus and excellent T cell responses without any side effects.

Serum Institute in India has pumped in nearly Rs. 1500 crores to bring the oxford vaccine for public use in India at Rs. 1,000 per vaccine within this year. But it depends on the next round of human trials. And also on the approval of the Indian government.

Exit mobile version